White-collar lawyer and former U.S. attorney Neil MacBride has rejoined Davis, Polk & Wardwell following a two-year stint as ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...

At the Capability Leaders Forum, marketers from AstraZeneca, Reckitt and Trainline discussed the potential of genAI to ...

Palivizumab injection is used to prevent serious lung infection in children and babies caused by respiratory syncytial virus ...

Listed Tyneside pharmaceutical firm Shield Therapeutics has appointed a new CEO. The Gateshead drug discovery business, which ...

Secretary of State for Science, Innovation and Technology Rt Hon Peter Kyle and Minister of State for Science, Research and ...

First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant ...

The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...

MULTINATIONAL pharmaceutical firm AstraZeneca (AZ) wants to conduct the majority of its clinical trials in the Philippines, ...

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

AstraZeneca will expand the its global R&D hub in Mississauga. This $820 million investment underscores Ontario ’s growing ...